Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity

Immunologic Research

Volumn 50, Issue 2-3, 2011, Pages 130-152

  Di Caro, Valentina ^a,b   D'Anneo, Antonella ^a,c   Phillips, Brett ^a   Engman, Carl ^a   Harnaha, Jo ^a   Trucco, Massimo ^a   Giannoukakis, Nick ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b RiMED Foundation   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Dendritic cells; Immunoregulation; Oligonucleotides; Phosphatidylinositol 3 kinase; Signaling; TLR

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CD11B ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CD8ALPHA ANTIGEN; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHATIDYLINOSITOL 3 KINASE; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVITY; CELL LINE; DENDRITIC CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD11C; BONE MARROW CELLS; CHROMONES; CYTOKINES; DENDRITIC CELLS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MORPHOLINES; OLIGONUCLEOTIDES; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 79961168904     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-011-8206-1     Document Type: Article

References (140)

1. DA Fruman G Bismuth 2009 Fine tuning the immune response with PI3K Immunol Rev 228 1 253 272 19290933 1:CAS:528:DC%2BD1MXhsFGls7vI
2. A Ghigo F Damilano L Braccini E Hirsch 2010 PI3K inhibition in inflammation: toward tailored therapies for specific diseases Bioessays 32 3 185 196 20162662 1:CAS:528:DC%2BC3cXksFCrsbs%3D
3. S Koyasu 2003 The role of PI3K in immune cells Nat Immunol 4 4 313 319 12660731 1:CAS:528:DC%2BD3sXitlyqsrg%3D
4. S Bhattacharyya P Sen M Wallet B Long AS Baldwin Jr R Tisch 2004 Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IkappaB kinase activity Blood 104 4 1100 1109 15113757 1:CAS:528:DC%2BD2cXmslKgsLs%3D (Pubitemid 39038031)
5. AD Foey M Feldmann FM Brennan 2001 CD40 ligation induces macrophage IL-10 and TNF-alpha production: differential use of the PI3K and p42/44 MAPK-pathways Cytokine 16 4 131 142 11792123 1:CAS:528:DC%2BD38XjsFehtw%3D%3D (Pubitemid 34112118)
6. B Frossi J Rivera E Hirsch C Pucillo 2007 Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition J Immunol 178 4 2549 2555 17277164 1:CAS:528:DC%2BD2sXht1Cnsbs%3D (Pubitemid 46233457)
7. T Fukao M Tanabe Y Terauchi T Ota S Matsuda T Asano T Kadowaki T Takeuchi S Koyasu 2002 PI3K-mediated negative feedback regulation of IL-12 production in DCs Nat Immunol 3 9 875 881 12154357 1:CAS:528:DC%2BD38Xms1agsrs%3D
8. BM Neves MT Cruz V Francisco C Garcia-Rodriguez R Silvestre A Cordeiro-da-Silva AM Dinis MT Batista CB Duarte MC Lopes 2009 Differential roles of PI3-Kinase, MAPKs and NF-kappaB on the manipulation of dendritic cell T(h)1/T(h)2 cytokine/chemokine polarizing profile Mol Immunol 46 13 2481 2492 19520433 1:CAS:528:DC%2BD1MXos1OmtbY%3D
9. K Okkenhaug B Vanhaesebroeck 2003 PI3K in lymphocyte development, differentiation and activation Nat Rev 3 4 317 330 1:CAS:528: DC%2BD3sXisFWku70%3D (Pubitemid 37328684)
10. RK Patel C Mohan 2005 PI3K/AKT signaling and systemic autoimmunity Immunol Res 31 1 47 55 15591622 1:CAS:528:DC%2BD2MXktVSnsQ%3D%3D (Pubitemid 40065424)
11. T Weichhart MD Saemann 2008 The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications Ann Rheum Dis 67 Suppl 3 iii70 iii74 19022819 1:CAS:528:DC%2BD1MXjt1Olsw%3D%3D
12. SJ Harris JG Foster SG Ward 2009 PI3K isoforms as drug targets in inflammatory diseases: lessons from pharmacological and genetic strategies Curr Opin Investig Drugs 10 11 1151 1162 19876783 1:CAS:528:DC%2BC3cXnt1Khtb0%3D
13. E Caparros P Munoz E Sierra-Filardi D Serrano-Gomez A Puig-Kroger JL Rodriguez-Fernandez M Mellado J Sancho M Zubiaur AL Corbi 2006 DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production Blood 107 10 3950 3958 16434485 1:CAS:528:DC%2BD28XkvFWhu78%3D (Pubitemid 43726801)
14. C Guiducci C Ghirelli MA Marloie-Provost T Matray RL Coffman YJ Liu FJ Barrat V Soumelis 2008 PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation J Exp Med 205 2 315 322 18227218 1:CAS:528: DC%2BD1cXisVeht7g%3D (Pubitemid 351281597)
15. S Karakhanova S Meisel S Ring K Mahnke AH Enk 2010 ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets Eur J Immunol 40 1 254 266 19830728 1:CAS:528:DC%2BC3cXktVKg
16. J Xie J Qian J Yang S Wang ME Freeman 3rd Q Yi 2005 Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells Exp Hematol 33 5 564 572 15850834 1:CAS:528:DC%2BD2MXjsFKhs70%3D (Pubitemid 40592173)
17. T Fukao S Koyasu 2003 PI3K and negative regulation of TLR signaling Trends Immunol 24 7 358 363 12860525 1:CAS:528:DC%2BD3sXlsVWltbs%3D (Pubitemid 36830961)
18. H An Y Yu M Zhang H Xu R Qi X Yan S Liu W Wang Z Guo J Guo, et al. 2002 Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells Immunology 106 1 38 45 11972630 1:CAS:528:DC%2BD38XjvVGgtbc%3D (Pubitemid 34437875)
19. Y Kumagai O Takeuchi S Akira 2008 TLR9 as a key receptor for the recognition of DNA Adv Drug Deliv Rev 60 7 795 804 18262306 1:CAS:528: DC%2BD1cXksVagsL4%3D
20. D Mitchell C Olive 2010 Regulation of toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases Mol Immunol 47 11-12 2065 2073 20451253 1:CAS:528:DC%2BC3cXmvFymu78%3D
21. M Ruse UG Knaus 2006 New players in TLR-mediated innate immunity: PI3K and small Rho GTPases Immunol Res 34 1 33 48 16720897 1:CAS:528: DC%2BD28XmtlOit7g%3D (Pubitemid 43780375)
22. EA Wohlfert RB Clark 2007 'Vive la resistance!'-the PI3K-Akt pathway can determine target sensitivity to regulatory T cell suppression Trends Immunol 28 4 154 160 17329168 1:CAS:528:DC%2BD2sXjslGrtbw%3D (Pubitemid 46467517)
23. J Banchereau RM Steinman 1998 Dendritic cells and the control of immunity Nature 392 6673 245 252 9521319 1:CAS:528:DyaK1cXitFWrsr8%3D (Pubitemid 28155090)
24. MB Lutz G Schuler 2002 Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23 9 445 449 12200066 1:CAS:528:DC%2BD38XmsVekuro%3D (Pubitemid 35015188)
25. RM Steinman D Hawiger MC Nussenzweig 2003 Tolerogenic dendritic cells Annu Rev Immunol 21 685 711 12615891 1:CAS:528:DC%2BD3sXjtF2is7g%3D (Pubitemid 37174545)
26. G Vlad R Cortesini N Suciu-Foca 2005 License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC J Immunol 174 10 5907 5914 15879080 1:CAS:528:DC%2BD2MXjvV2msLg%3D (Pubitemid 40663774)
27. T Nikolic JM Welzen-Coppens PJ Leenen HA Drexhage MA Versnel 2009 Plasmacytoid dendritic cells in autoimmune diabetes-potential tools for immunotherapy Immunobiology 214 9-10 791 799 19628297 1:CAS:528: DC%2BD1MXhtFags7zL
28. P Kalinski 2009 Dendritic cells in immunotherapy of established cancer: roles of signals 1, 2, 3 and 4 Curr Opin Investig Drugs 10 6 526 535 19513941 1:CAS:528:DC%2BC3cXnt1Khsr0%3D
29. CJ Melief 2008 Cancer immunotherapy by dendritic cells Immunity 29 3 372 383 18799145 1:CAS:528:DC%2BD1cXhtF2jtLvF
30. A Nencioni F Grunebach SM Schmidt MR Muller D Boy F Patrone A Ballestrero P Brossart 2008 The use of dendritic cells in cancer immunotherapy Crit Rev Oncol Hematol 65 3 191 199 18055210 (Pubitemid 351200461)
31. RS Kornbluth GW Stone 2006 Immunostimulatory combinations: designing the next generation of vaccine adjuvants J Leukoc Biol 80 5 1084 1102 16931603 1:CAS:528:DC%2BD28XhtFOktrfL (Pubitemid 44646314)
32. K Mahnke E Schmitt L Bonifaz AH Enk H Jonuleit 2002 Immature, but not inactive: the tolerogenic function of immature dendritic cells Immunol Cell Biol 80 5 477 483 12225384
33. M Nouri-Shirazi AW Thomson 2006 Dendritic cells as promoters of transplant tolerance Expert Opin Biol Ther 6 4 325 339 16548761 1:CAS:528:DC%2BD28XivVOmtr4%3D
34. R Bottino P Lemarchand M Trucco N Giannoukakis 2003 Gene- and cell-based therapeutics for type I diabetes mellitus Gene Ther 10 10 875 889 12732873 1:CAS:528:DC%2BD3sXjsVWrtLw%3D (Pubitemid 36665298)
35. D Chen R Sung JS Bromberg 2002 Gene therapy in transplantation Transpl Immunol 9 2-4 301 314 12180845 1:CAS:528:DC%2BD38Xltlektbg%3D (Pubitemid 34863399)
36. N Giannoukakis M Trucco 2005 Gene therapy for type 1 diabetes Am J Ther 12 6 512 528 16280645 (Pubitemid 41689752)
37. IH Tarner AJ Slavin J McBride A Levicnik R Smith GP Nolan CH Contag CG Fathman 2003 Treatment of autoimmune disease by adoptive cellular gene therapy Ann N Y Acad Sci 998 512 519 14592922 1:CAS:528:DC%2BD3sXosFyntbw%3D (Pubitemid 37194206)
38. M Trucco PD Robbins AW Thomson N Giannoukakis 2002 Gene therapy strategies to prevent autoimmune disorders Curr Gene Ther 2 3 341 354 12189720 1:CAS:528:DC%2BD38XmtF2rsLc%3D
39. W Chen 2006 Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance Front Biosci 11 1360 1370 16368522 1:CAS:528:DC%2BD28XislSgu7g%3D (Pubitemid 43253428)
40. S Hugues A Boissonnas S Amigorena L Fetler 2006 The dynamics of dendritic cell-T cell interactions in priming and tolerance Curr Opin Immunol 18 4 491 495 16765575 1:CAS:528:DC%2BD28XmsFSks74%3D (Pubitemid 43965001)
41. S Beissert A Schwarz T Schwarz 2006 Regulatory T cells J Invest Dermatol 126 1 15 24 16417213 1:CAS:528:DC%2BD28Xlt1WjtbY%3D (Pubitemid 43336089)
42. AH Enk 2006 DCs and cytokines cooperate for the induction of Tregs Ernst Schering Res Found Workshop 56 97 106 16329648
43. S Huber C Schramm 2006 TGF-beta and CD4+ CD25+ regulatory T cells Front Biosci 11 1014 1023 16146793 1:CAS:528:DC%2BD2MXhtlSrurfO (Pubitemid 43253457)
44. J Lohr B Knoechel AK Abbas 2006 Regulatory T cells in the periphery Immunol Rev 212 149 162 16903912 1:CAS:528:DC%2BD28XpvFegt7s%3D (Pubitemid 44116706)
45. MG Roncarolo S Gregori M Battaglia R Bacchetta K Fleischhauer MK Levings 2006 Interleukin-10-secreting type 1 regulatory T cells in rodents and humans Immunol Rev 212 28 50 16903904 1:CAS:528:DC%2BD28XpvFegtr4%3D (Pubitemid 44116698)
46. EM Shevach RA DiPaolo J Andersson DM Zhao GL Stephens AM Thornton 2006 The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells Immunol Rev 212 60 73 16903906 1:CAS:528:DC%2BD28XpvFegtro%3D (Pubitemid 44116700)
47. Q Tang JA Bluestone 2006 Regulatory T-cell physiology and application to treat autoimmunity Immunol Rev 212 217 237 16903917 1:CAS:528: DC%2BD28XpvFegtLo%3D (Pubitemid 44116711)
48. J Verhagen K Blaser CA Akdis M Akdis 2006 Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more Immunol Allergy Clin North Am 26 2 207 231 16701141
49. L Zhang H Yi XP Xia Y Zhao 2006 Transforming growth factor-beta: an important role in CD4+ CD25+ regulatory T cells and immune tolerance Autoimmunity 39 4 269 276 16891215 1:CAS:528:DC%2BD28Xptlalu78%3D (Pubitemid 44203503)
50. DH Munn MD Sharma JR Lee KG Jhaver TS Johnson DB Keskin B Marshall P Chandler SJ Antonia R Burgess, et al. 2002 Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase Science 297 5588 1867 1870 12228717 1:CAS:528:DC%2BD38Xnt1Shsro%3D (Pubitemid 35024345)
51. AL Mellor P Chandler B Baban AM Hansen B Marshall J Pihkala H Waldmann S Cobbold E Adams DH Munn 2004 Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase Int Immunol 16 10 1391 1401 15351783 1:CAS:528:DC%2BD2cXns1OmsL0%3D (Pubitemid 39341552)
52. AL Mellor DH Munn 2004 IDO expression by dendritic cells: tolerance and tryptophan catabolism Nat Rev Immunol 4 10 762 774 15459668 1:CAS:528: DC%2BD2cXotVSlsLg%3D (Pubitemid 39336293)
53. SS Ahuja 2001 In vitro generation of functional human and murine dendritic cells Methods Mol Biol (Clifton, NJ) 156 67 77 1:CAS:528: DC%2BD3cXntFKmtr4%3D
54. D Anton S Dabadghao K Palucka G Holm Q Yi 1998 Generation of dendritic cells from peripheral blood adherent cells in medium with human serum Scand J Immunol 47 2 116 121 9496685 1:STN:280:DyaK1c7ls1eksw%3D%3D (Pubitemid 28122791)
55. H Bernhard ML Disis S Heimfeld S Hand JR Gralow MA Cheever 1995 Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood Cancer Res 55 5 1099 1104 7532543 1:CAS:528:DyaK2MXktVGiur8%3D
56. P Brossart F Grunebach G Stuhler VL Reichardt R Mohle L Kanz W Brugger 1998 Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor Blood 92 11 4238 4247 9834229 1:CAS:528: DyaK1cXnslylsb8%3D (Pubitemid 28544340)
57. H Cao V Verge C Baron C Martinache A Leon S Scholl NC Gorin J Salamero S Assari J Bernard, et al. 2000 In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy J Hematother Stem Cell Res 9 2 183 194 10813531 1:STN:280:DC%2BD3cvgtlaqsQ%3D%3D (Pubitemid 30305123)
58. JC Gluckman B Canque F Chapuis M Rosenzwajg 1997 In vitro generation of human dendritic cells and cell therapy Cytokines Cell Mol Ther 3 3 187 196 9426977 1:STN:280:DyaK1c%2FovVCitA%3D%3D (Pubitemid 27448282)
59. K Inaba M Inaba N Romani H Aya M Deguchi S Ikehara S Muramatsu RM Steinman 1992 Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor J Exp Med 176 6 1693 1702 1460426 1:STN:280:DyaK3s%2FpsVOktw%3D%3D
60. F Manca G Li Pira D Fenoglio SP Fang A Habeshaw SC Knight AG Dalgleish 1994 Dendritic cells are potent antigen-presenting cells for in vitro induction of primary human CD4+ T-cell lines specific for HIV gp120 J Acquir Immune Defic Syndr 7 1 15 23 7903379 1:CAS:528:DyaK2cXisVagsLY%3D
61. M Ratta D Rondelli A Fortuna A Curti M Fogli F Fagnoni G Martinelli C Terragna S Tura RM Lemoli 1998 Generation and functional characterization of human dendritic cells derived from CD34 cells mobilized into peripheral blood: comparison with bone marrow CD34+ cells Br J Haematol 101 4 756 765 9674752 1:CAS:528:DyaK1cXltVSgtLk%3D (Pubitemid 28308528)
62. N Romani D Reider M Heuer S Ebner E Kampgen B Eibl D Niederwieser G Schuler 1996 Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability J Immunol Methods 196 2 137 151 8841452 1:CAS:528:DyaK28XlsFWrtLg%3D (Pubitemid 26306735)
63. S Arab M Motamedi N Khansari SM Moazzeni Z Gheflati J Hadjati 2006 Dendritic cell maturation with CpG for tumor immunotherapy Iran J Immunol 3 3 99 105 18698118 (Pubitemid 44784015)
64. A Iparraguirre JW Tobias SE Hensley KS Masek LL Cavanagh M Rendl CA Hunter HC Ertl UH von Andrian W Weninger 2008 Two distinct activation states of plasmacytoid dendritic cells induced by influenza virus and CpG 1826 oligonucleotide J Leukoc Biol 83 3 610 620 18029397 1:CAS:528: DC%2BD1cXjtVaqtL4%3D (Pubitemid 351966871)
65. KW Lee DS Kim HJ Kwon 2004 CG sequence- and phosphorothioate backbone modification-dependent activation of the NF-kappaB-responsive gene expression by CpG-oligodeoxynucleotides in human RPMI 8226 B cells Mol Immunol 41 10 955 964 15302158 1:CAS:528:DC%2BD2cXmtlOlurc%3D
66. T Switaj A Jalili AB Jakubowska N Drela M Stoksik D Nowis G Basak J Golab PJ Wysocki A Mackiewicz, et al. 2004 CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in mice Clin Cancer Res 10 12 Pt 1 4165 4175 15217954 1:CAS:528:DC%2BD2cXltFWmu7g%3D (Pubitemid 38812497)
67. N Giannoukakis CA Bonham S Qian Z Zhou L Peng J Harnaha W Li AW Thomson JJ Fung PD Robbins, et al. 2000 Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides Mol Ther 1 5 Pt 1 430 437 10933964 1:CAS:528:DC%2BD38XhvF2iu7w%3D (in process citation)
68. J Machen J Harnaha R Lakomy A Styche M Trucco N Giannoukakis 2004 Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells J Immunol 173 7 4331 4341 15383562 1:CAS:528:DC%2BD2cXnslWmsb8%3D (Pubitemid 39280661)
69. L Adorini N Giarratana G Penna 2004 Pharmacological induction of tolerogenic dendritic cells and regulatory T cells Semin Immunol 16 2 127 134 15036236 1:CAS:528:DC%2BD2cXht1KhtbY%3D (Pubitemid 38234763)
70. AW Thomson PD Robbins 2008 Tolerogenic dendritic cells for autoimmune disease and transplantation Ann Rheum Dis 67 Suppl 3 iii90 iii96 19022823 1:CAS:528:DC%2BD1MXjt1Oltg%3D%3D
71. Antignano F, Ibaraki M, Ruschmann J, Jagdeo J, Krystal G. SHIP negatively regulates Flt3L-derived dendritic cell generation and positively regulates MyD88-independent TLR-induced maturation. J Leukoc Biol.
72. F Antignano M Ibaraki C Kim J Ruschmann A Zhang CD Helgason G Krystal 2010 SHIP is required for dendritic cell maturation J Immunol 184 6 2805 2813 20154203 1:CAS:528:DC%2BC3cXis1yis7o%3D
73. L van de Laar M Buitenhuis FM Wensveen HL Janssen PJ Coffer AM Woltman 2010 Human CD34-derived myeloid dendritic cell development requires intact phosphatidylinositol 3-kinase-protein kinase B-mammalian target of rapamycin signaling J Immunol 184 12 6600 6611 20488790
74. AS Lo P Gorak-Stolinska V Bachy MA Ibrahim DM Kemeny J Maher 2007 Modulation of dendritic cell differentiation by colony-stimulating factor-1: role of phosphatidylinositol 3′-kinase and delayed caspase activation J Leukoc Biol 82 6 1446 1454 17855501 1:CAS:528:DC%2BD2sXhsValur7M (Pubitemid 350276956)
75. PR Kramer V Winger J Reuben 2009 PI3K limits TNF-alpha production in CD16-activated monocytes Eur J Immunol 39 2 561 570 19180470 1:CAS:528:DC%2BD1MXitlGjs74%3D
76. F Fu Y Li S Qian L Lu F Chambers TE Starzl JJ Fung AW Thomson 1996 Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients Transplantation 62 5 659 665 8830833 1:CAS:528:DyaK28Xmtlyksrw%3D (Pubitemid 26313912)
77. L Lu WA Rudert S Qian D McCaslin F Fu AS Rao M Trucco JJ Fung TE Starzl AW Thomson 1995 Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor J Exp Med 182 2 379 387 7629500 1:CAS:528: DyaK2MXntFKhs7w%3D
78. E Shumilina N Zahir NT Xuan F Lang 2007 Phosphoinositide 3-kinase dependent regulation of Kv channels in dendritic cells Cell Physiol Biochem 20 6 801 808 17982262 1:CAS:528:DC%2BD2sXht1CkurfM (Pubitemid 350059723)
79. E Aksoy W Vanden Berghe S Detienne Z Amraoui KA Fitzgerald G Haegeman M Goldman F Willems 2005 Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of toll-like receptor 3 and 4 Eur J Immunol 35 7 2200 2209 15940673 1:CAS:528:DC%2BD2MXmvVeisr4%3D (Pubitemid 41015059)
80. E Liu HK Law YL Lau 2003 Insulin-like growth factor I promotes maturation and inhibits apoptosis of immature cord blood monocyte-derived dendritic cells through MEK and PI 3-kinase pathways Pediatr Res 54 6 919 925 12930919 1:CAS:528:DC%2BD3sXptV2jtLY%3D (Pubitemid 37456559)
81. Bhattacharya P, Gopisetty A, Ganesh BB, Sheng JR, Prabhakar BS. GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms. J Leukoc Biol. 2010.
82. H Li GX Zhang Y Chen H Xu DC Fitzgerald Z Zhao A Rostami 2008 CD11c+ CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis J Immunol 181 4 2483 2493 18684939 1:CAS:528:DC%2BD1cXptlKqurc%3D
83. Q Liu C Zhang A Sun Y Zheng L Wang X Cao 2009 Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I J Immunol 182 10 6207 6216 19414774 1:CAS:528:DC%2BD1MXltlyntbo%3D
84. SP Cobbold 2002 T cell tolerance in transplantation: possibilities for therapeutic intervention Expert Opin Ther Targets 6 5 583 599 12387682 1:CAS:528:DC%2BD38XovFaitro%3D (Pubitemid 35175107)
85. K Hochweller SM Anderton 2005 Kinetics of costimulatory molecule expression by T cells and dendritic cells during the induction of tolerance versus immunity in vivo Eur J Immunol 35 4 1086 1096 15756642 1:CAS:528:DC%2BD2MXjslSgtL0%3D (Pubitemid 40542215)
86. A Chhabra NG Chakraborty B Mukherji 2008 Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-1 27-35 Clin Immunol 126 3 251 259 18249038 1:CAS:528:DC%2BD1cXitVWlurY%3D
87. NC Gundacker VJ Haudek H Wimmer A Slany J Griss V Bochkov C Zielinski O Wagner J Stockl C Gerner 2009 Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells J Proteome Res 8 6 2799 2811 19351150 1:CAS:528:DC%2BD1MXlvVWmtrY%3D
88. WH Kwan C Boix N Gougelet WH Fridman CG Mueller 2007 LPS induces rapid IL-10 release by M-CSF-conditioned tolerogenic dendritic cell precursors J Leukoc Biol 82 1 133 141 17470530 1:CAS:528:DC%2BD2sXnvVWktrg%3D (Pubitemid 47026425)
89. K Mnasria C Lagaraine J Manaa Y Lebranchu R Oueslati 2008 Anti CD25 treatment of human dendritic cells modulates both their cytokine synthesis profiles and their capacity to activate allogeneic CD4 T cells: a potential tolerogenic effect Int Immunopharmacol 8 3 414 422 18279795 1:CAS:528: DC%2BD1cXitVGhs7w%3D
90. G Ureta F Osorio J Morales M Rosemblatt MR Bono JA Fierro 2007 Generation of dendritic cells with regulatory properties Transpl Proc 39 3 633 637 1:CAS:528:DC%2BD2sXksVOmtrY%3D (Pubitemid 46574813)
91. IJ Crane JV Forrester 2005 Th1 and Th2 lymphocytes in autoimmune disease Crit Rev Immunol 25 2 75 102 15952931 1:CAS:528:DC%2BD2sXktleit7k%3D (Pubitemid 40910583)
92. A Kutlu B Bozkurt F Ciftci E Bozkanat 2007 Th1-Th2 interaction: is more complex than a see-saw? Scand J Immunol 65 4 393 395 17386031 1:CAS:528:DC%2BD2sXlsVCmtrk%3D (Pubitemid 46481108)
93. RB Moss T Moll M El-Kalay C Kohne W Soo Hoo J Encinas DJ Carlo 2004 Th1/Th2 cells in inflammatory disease states: therapeutic implications Exp Opin Biol Ther 4 12 1887 1896 1:CAS:528:DC%2BD2cXhtVaqtL3I (Pubitemid 39627140)
94. J Pirenne H Kitade M Kawai T Koshiba B Van Damme C Mathieu M Waer 2005 Regulatory cells, TH1/TH2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion Transplantation 79 3 Suppl S25 S27 15699741 1:CAS:528:DC%2BD2MXhtV2ktr4%3D
95. M Utsugi K Dobashi A Ono T Ishizuka S Matsuzaki T Hisada Y Shimizu T Kawata H Aoki Y Kamide, et al. 2009 PI3K p110beta positively regulates lipopolysaccharide-induced IL-12 production in human macrophages and dendritic cells and JNK1 plays a novel role J Immunol 182 9 5225 5231 19380768 1:CAS:528:DC%2BD1MXkslKju7o%3D
96. JD Kamda SM Singer 2009 Phosphoinositide 3-kinase-dependent inhibition of dendritic cell interleukin-12 production by Giardia lamblia Infect Immun 77 2 685 693 19047410 1:CAS:528:DC%2BD1MXhs1Shs7s%3D
97. M Ohtani S Nagai S Kondo S Mizuno K Nakamura M Tanabe T Takeuchi S Matsuda S Koyasu 2008 Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells Blood 112 3 635 643 18492954 1:CAS:528:DC%2BD1cXpsVaju7o%3D
98. A Agrawal S Agrawal JN Cao H Su K Osann S Gupta 2007 Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway J Immunol 178 11 6912 6922 17513740 1:CAS:528:DC%2BD2sXlsVOmsLo%3D (Pubitemid 46847417)
99. J Vollmer 2005 Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9 Exp Opin Biol Ther 5 5 673 682 1:CAS:528:DC%2BD2MXltlSht7k%3D (Pubitemid 40780550)
100. M Martin K Rehani RS Jope SM Michalek 2005 Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3 Nat Immunol 6 8 777 784 16007092 1:CAS:528:DC%2BD2MXmtlSisL0%3D (Pubitemid 43090463)
101. K Pan H Wang WL Liu HK Zhang J Zhou JJ Li DS Weng W Huang JC Sun XT Liang, et al. 2009 The pivotal role of p38 and NF-kappaB signal pathways in the maturation of human monocyte-derived dendritic cells stimulated by streptococcal agent OK-432 Immunobiology 214 5 350 358 19362680 1:CAS:528: DC%2BD1MXlsFSnuro%3D
102. S Trompezinski C Migdal M Tailhardat B Le Varlet P Courtellemont M Haftek M Serres 2008 Characterization of early events involved in human dendritic cell maturation induced by sensitizers: cross talk between MAPK signalling pathways Toxicol Appl Pharmacol 230 3 397 406 18495191 1:CAS:528:DC%2BD1cXosVOjsLg%3D
103. T Luft E Rodionova E Maraskovsky M Kirsch M Hess C Buchholtz M Goerner M Schnurr R Skoda AD Ho 2006 Adaptive functional differentiation of dendritic cells: integrating the network of extra- and intracellular signals Blood 107 12 4763 4769 16527899 1:CAS:528:DC%2BD28XlvFCgtro%3D (Pubitemid 43882627)
104. T Nakahara Y Moroi H Uchi M Furue 2006 Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement J Dermatol Sci 42 1 1 11 16352421 1:CAS:528:DC%2BD28Xit1KqtLs%3D (Pubitemid 43384125)
105. F Hua PV Henstock B Tang 2010 ERK activation by GM-CSF reduces effectiveness of p38 inhibitor on inhibiting TNFalpha release Int Immunopharmacol 10 7 730 737 20398804 1:CAS:528:DC%2BC3cXntVagsbY%3D
106. S Lendemans M Rani C Selbach E Kreuzfelder FU Schade S Flohe 2006 GM-CSF priming of human monocytes is dependent on ERK1/2 activation J Endotoxin Res 12 1 10 20 16420740 1:CAS:528:DC%2BD28XhsFKmtrY%3D (Pubitemid 43169510)
107. S Nagafuchi H Katsuta Y Ohno Y Inoue K Shimoda K Kogawa Y Ikeda R Koyanagi-Katsuta S Yamasaki H Tominaga, et al. 2005 Mitogen-activated protein kinase pathway controls autoimmune regulator (AIRE) gene expression in granulo-monocyte colony stimulating factor (GM-CSF)-stimulated myelomonocytic leukemia OTC-4 cells Immunol Lett 99 1 130 135 15894121 1:CAS:528: DC%2BD2MXkt1Crtr0%3D (Pubitemid 40718944)
108. H Nagayama K Sato H Kawasaki M Enomoto C Morimoto K Tadokoro T Juji S Asano TA Takahashi 2000 IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells J Immunol 165 1 59 66 10861035 1:CAS:528:DC%2BD3cXksVKlsrk%3D (Pubitemid 30429490)
109. GK Koski LA Lyakh PA Cohen NR Rice 2001 CD14+ monocytes as dendritic cell precursors: diverse maturation-inducing pathways lead to common activation of NF-kappab/RelB Crit Rev Immunol 21 1-3 179 189 11642603 1:CAS:528: DC%2BD3MXnvVCrurw%3D (Pubitemid 32959360)
110. M Stepnik J Arkusz 2003 Molecular events associated with dendritic cells activation by contact sensitizers Int J Occup Med Environ Health 16 3 191 199 14587531 (Pubitemid 37266270)
111. K Rehani H Wang CA Garcia DF Kinane M Martin 2009 Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1/2 J Immunol 182 1 547 553 19109187 1:CAS:528:DC%2BD1cXhsFCisLzI
112. X Hu PK Paik J Chen A Yarilina L Kockeritz TT Lu JR Woodgett LB Ivashkiv 2006 IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins Immunity 24 5 563 574 16713974 1:CAS:528:DC%2BD28XlsFWqtrY%3D (Pubitemid 43728157)
113. K Spinnler M Mezger M Steffens H Sennefelder O Kurzai H Einsele J Loeffler 2010 Role of glycogen synthase kinase 3 (GSK-3) in innate immune response of human immature dendritic cells to Aspergillus fumigatus Med Mycol 48 4 589 597 20055739 1:CAS:528:DC%2BC3cXlvFOiur4%3D
114. CF Lin CC Tsai WC Huang CY Wang HC Tseng Y Wang JI Kai SW Wang YL Cheng 2008 IFN-gamma synergizes with LPS to induce nitric oxide biosynthesis through glycogen synthase kinase-3-inhibited IL-10 J Cell Biochem 105 3 746 755 18655171 1:CAS:528:DC%2BD1cXht1Ojsr7F
115. E Rodionova M Conzelmann E Maraskovsky M Hess M Kirsch T Giese AD Ho M Zoller P Dreger T Luft 2007 GSK-3 mediates differentiation and activation of proinflammatory dendritic cells Blood 109 4 1584 1592 17032918 1:CAS:528:DC%2BD2sXjt1Cgsb4%3D (Pubitemid 46239592)
116. K Duperrier FW Velten J Bohlender A Demory P Metharom S Goerdt 2005 Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes Mol Immunol 42 12 1531 1540 15950746 1:CAS:528:DC%2BD2MXkvFWjs7g%3D (Pubitemid 40798940)
117. L Lu WC Lee T Takayama S Qian A Gambotto PD Robbins AW Thomson 1999 Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-beta, and CTLA4Ig) J Leukoc Biol 66 2 293 296 10449170 1:CAS:528:DyaK1MXlt1ejt7g%3D (Pubitemid 29379171)
118. A Wada 2009 GSK-3 inhibitors and insulin receptor signaling in health, disease, and therapeutics Front Biosci 14 1558 1570 19273146 1:CAS:528:DC%2BD1MXltFeju7Y%3D
119. K MacAulay JR Woodgett 2008 Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes Expert Opin Ther Targets 12 10 1265 1274 18781825 1:CAS:528:DC%2BD1cXhtFSmsrnP
120. I Mucci A Legitimo M Compagnino R Consolini P Migliaccio MR Metelli F Scatena 2009 The methodological approach for the generation of human dendritic cells from monocytes affects the maturation state of the resultant dendritic cells Biologicals 37 5 288 296 19665905 1:CAS:528:DC%2BD1MXhtV2qsbjN
121. E Elkord PE Williams H Kynaston AW Rowbottom 2005 Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells Immunology 114 2 204 212 15667565 1:CAS:528:DC%2BD2MXht12mtro%3D (Pubitemid 40208937)
122. M Colic S Mojsilovic B Pavlovic D Vucicevic I Majstorovic B Bufan Z Stojic-Vukanic S Vasilijic D Vucevic S Gasic, et al. 2004 Comparison of two different protocols for the induction of maturation of human dendritic cells in vitro Vojnosanit Pregl 61 5 471 478 15551798
123. TF Franke 2008 PI3K/Akt: getting it right matters Oncogene 27 50 6473 6488 18955974 1:CAS:528:DC%2BD1cXht12ltLvN
124. TF Franke CP Hornik L Segev GA Shostak C Sugimoto 2003 PI3K/Akt and apoptosis: size matters Oncogene 22 56 8983 8998 14663477 1:CAS:528: DC%2BD3sXpsFOmsrg%3D (Pubitemid 38121699)
125. JA McCubrey LS Steelman SL Abrams FE Bertrand DE Ludwig J Basecke M Libra F Stivala M Milella A Tafuri, et al. 2008 Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy Leukemia 22 4 708 722 18337766 1:CAS:528: DC%2BD1cXks12rtbo%3D (Pubitemid 351565619)
126. DC Cho MB Cohen DJ Panka M Collins M Ghebremichael MB Atkins S Signoretti JW Mier 2010 The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma Clin Cancer Res 16 14 3628 3638 20606035 1:CAS:528:DC%2BC3cXovVansbk%3D
127. M Fujiwara K Izuishi T Sano MA Hossain S Kimura T Masaki Y Suzuki 2008 Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells J Exp Clin Cancer Res 27 76 19032736
128. A Burchert Y Wang D Cai N von Bubnoff P Paschka S Muller-Brusselbach OG Ottmann J Duyster A Hochhaus A Neubauer 2005 Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development Leukemia 19 10 1774 1782 16136169 1:CAS:528:DC%2BD2MXhtVags7vN (Pubitemid 41486155)
129. R Aikawa M Nawano Y Gu H Katagiri T Asano W Zhu R Nagai I Komuro 2000 Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt Circulation 102 23 2873 2879 11104747 1:CAS:528:DC%2BD3cXptVSjtrY%3D
130. MJ Rane PY Coxon DW Powell R Webster JB Klein W Pierce P Ping KR McLeish 2001 p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide- dependent kinase-2 for Akt in human neutrophils J Biol Chem 276 5 3517 3523 11042204 1:CAS:528:DC%2BD3MXhtFWisL4%3D
131. E Berra MT Diaz-Meco J Moscat 1998 The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway J Biol Chem 273 17 10792 10797 9553146 1:CAS:528:DyaK1cXivFKms7w%3D (Pubitemid 28227697)
132. JP Gratton M Morales-Ruiz Y Kureishi D Fulton K Walsh WC Sessa 2001 Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells J Biol Chem 276 32 30359 30365 11387313 1:CAS:528:DC%2BD3MXmtFehtLs%3D
133. C Ammon K Mondal R Andreesen SW Krause 2000 Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells Biochem Biophys Res Commun 268 1 99 105 10652220 1:CAS:528:DC%2BD3cXnsVWmsQ%3D%3D (Pubitemid 30116618)
134. M Rescigno M Martino CL Sutherland MR Gold P Ricciardi-Castagnoli 1998 Dendritic cell survival and maturation are regulated by different signaling pathways J Exp Med 188 11 2175 2180 9841930 1:CAS:528:DyaK1cXnvFOgsr8%3D (Pubitemid 28562533)
135. RG Jones SD Saibil JM Pun AR Elford M Bonnard M Pellegrini S Arya ME Parsons CM Krawczyk S Gerondakis, et al. 2005 NF-kappaB couples protein kinase B/Akt signaling to distinct survival pathways and the regulation of lymphocyte homeostasis in vivo J Immunol 175 6 3790 3799 16148125 1:CAS:528: DC%2BD2MXpslCls7o%3D (Pubitemid 41292039)
136. PS Ohashi JR Woodgett 2005 Modulating autoimmunity: pick your PI3 kinase Nat Med 11 9 924 925 16145571 1:CAS:528:DC%2BD2MXpsleltb8%3D
137. JR Woodgett PS Ohashi 2005 GSK3: an in-toll-erant protein kinase? Nat Immunol 6 8 751 752 16034428 1:CAS:528:DC%2BD2MXmtlSis7s%3D (Pubitemid 43090457)
138. N Dil AJ Marshall 2009 Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation Mol Immunol 46 10 1970 1978 19362372 1:CAS:528:DC%2BD1MXlvFGis78%3D
139. C Hoarau B Gerard E Lescanne D Henry S Francois JJ Lacapere J El Benna PM Dang B Grandchamp Y Lebranchu, et al. 2007 TLR9 activation induces normal neutrophil responses in a child with IRAK-4 deficiency: involvement of the direct PI3K pathway J Immunol 179 7 4754 4765 17878374 1:CAS:528: DC%2BD2sXhtVCrurvJ
140. DP Sester K Brion A Trieu HS Goodridge TL Roberts J Dunn DA Hume KJ Stacey MJ Sweet 2006 CpG DNA activates survival in murine macrophages through TLR9 and the phosphatidylinositol 3-kinase-Akt pathway J Immunol 177 7 4473 4480 16982883 1:CAS:528:DC%2BD28Xps1GgtbY%3D (Pubitemid 44469777)